Vimarsana
Biggest News Aggregation in the World

Page 6 - Cm Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Management Today - Breaking & Trending Today

Pieris Pharmaceuticals (NASDAQ:PIRS) Research Coverage Started at StockNews.com - Vimarsana News

Pieris Pharmaceuticals (NASDAQ:PIRS) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note published on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of PIRS stock opened at $11.68 on Monday. The stock’s 50-day moving average is $13.73 and its two-hundred day […]

Source: wkrb13.com
Douglas N. Currault II Sells 55,000 Shares of Freeport-McMoRan Inc. (NYSE:FCX) Stock - Vimarsana News

Douglas N. Currault II Sells 55,000 Shares of Freeport-McMoRan Inc. (NYSE:FCX) Stock

Freeport-McMoRan Inc. (NYSE:FCX – Get Free Report) VP Douglas N. Currault II sold 55,000 shares of the business’s stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $51.99, for a total value of $2,859,450.00. Following the completion of the sale, the vice president now directly […]

Coya Therapeutics (NASDAQ:COYA) Receives "Buy" Rating from Chardan Capital - Vimarsana News

Coya Therapeutics (NASDAQ:COYA) Receives "Buy" Rating from Chardan Capital

Chardan Capital reissued their buy rating on shares of Coya Therapeutics (NASDAQ:COYA – Free Report) in a research note released on Monday, Benzinga reports. Chardan Capital currently has a $14.00 price objective on the stock. Coya Therapeutics Trading Down 3.6 % Shares of NASDAQ:COYA opened at $8.72 on Monday. The stock has a market capitalization […]

Source: wkrb13.com
Brokerages Set DURECT Co. (NASDAQ:DRRX) PT at $27.50 - Vimarsana News

Brokerages Set DURECT Co. (NASDAQ:DRRX) PT at $27.50

Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the five research firms that are presently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 […]

Nektar Therapeutics (NASDAQ:NKTR) Given Average Recommendation of "Hold" by Brokerages - Vimarsana News

Nektar Therapeutics (NASDAQ:NKTR) Given Average Recommendation of "Hold" by Brokerages

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received an average rating of “Hold” from the five research firms that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating on the […]